Literature DB >> 23596245

High rates of inducible clindamycin resistance among prenatal group B streptococcal isolates in one northwest Louisiana academic medical center.

Gerald A Capraro, Ellen D Rambin, John A Vanchiere, Joseph A Bocchini, Janice M Matthews-Greer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23596245      PMCID: PMC3697681          DOI: 10.1128/JCM.00279-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

1.  High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital.

Authors:  Ephraim E Back; Elisa J O'Grady; Joshua D Back
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.

Authors:  Jennifer R Verani; Lesley McGee; Stephanie J Schrag
Journal:  MMWR Recomm Rep       Date:  2010-11-19

3.  Evaluation of a new selective enrichment broth for detection of group B streptococci in pregnant women.

Authors:  Judith S Heelan; Judith Struminsky; Patricia Lauro; C James Sung
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

4.  High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus.

Authors:  Linda P DiPersio; Joseph R DiPersio
Journal:  Diagn Microbiol Infect Dis       Date:  2006-01       Impact factor: 2.803

5.  Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.

Authors:  Scott E Gygax; Jessica A Schuyler; Lauren E Kimmel; Jason P Trama; Eli Mordechai; Martin E Adelson
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

6.  Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women.

Authors:  Shannon D Manning; Betsy Foxman; Carl L Pierson; Patricia Tallman; Carol J Baker; Mark D Pearlman
Journal:  Obstet Gynecol       Date:  2003-01       Impact factor: 7.661

7.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.

Authors:  Christina R Phares; Ruth Lynfield; Monica M Farley; Janet Mohle-Boetani; Lee H Harrison; Susan Petit; Allen S Craig; William Schaffner; Shelley M Zansky; Ken Gershman; Karen R Stefonek; Bernadette A Albanese; Elizabeth R Zell; Anne Schuchat; Stephanie J Schrag
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

8.  Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-05-31

9.  Patterns of antibiotic resistance among group B streptococcus isolates: 2001-2004.

Authors:  Lubna Chohan; Lisa M Hollier; Karen Bishop; Charles C Kilpatrick
Journal:  Infect Dis Obstet Gynecol       Date:  2006
  9 in total
  4 in total

1.  Invasive group B streptococcal infection in infants in Shenzhen, China.

Authors:  Jiaosheng Zhang; Ruizhen Zhao; Yimei Dong; Yuejie Zheng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Antimicrobial susceptibilities of group B streptococcus isolates from prenatal screening samples.

Authors:  Benjamin R Berg; Jeana L Houseman; Zachary E terSteeg; William D LeBar; Duane W Newton
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

3.  Evaluation of the Results of Group B Streptococcus Screening by MALDI-TOF MS among Pregnant Women in a Hungarian Hospital.

Authors:  Marianna Ábrók; Petra Tigyi; Markus Kostrzewa; Katalin Burián; Judit Deák
Journal:  Pathogens       Date:  2019-12-18

4.  Association of sexually-transmitted infection and African-American race with Streptococcus agalactiae colonization in pregnancy.

Authors:  Gerald A Capraro; Sajel Lala; Khaldia Khaled; Elizabeth Gosciniak; Brianna Saadat; Sarah M Alvarez; Seema Kumar; Tara Calhoun; Edward Landry; Gloria Caldito; Joseph A Bocchini; John A Vanchiere
Journal:  Antimicrob Resist Infect Control       Date:  2020-11-04       Impact factor: 4.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.